| Name | LARGE xylosyl- and glucuronyltransferase 2 |
| Description | Predicted to enable dystroglycan binding activity; glucuronosyltransferase activity; and xylosyltransferase activity. Involved in protein O-linked mannosylation. Predicted to be located in intracellular membrane-bounded organelle. Predicted to be active in Golgi apparatus. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n LARGE2 is a homolog of LARGE that functions as a bifunctional glycosyltransferase in the Golgi apparatus, where it catalyzes the sequential transfer of xylose and glucuronic acid moieties using UDP‐xylose and UDP‐glucuronic acid as donors. This enzymatic activity produces a repeating disaccharide polymer (“matriglycan”) that is essential for the functional glycosylation of α‐dystroglycan, conferring high‐affinity binding to extracellular matrix ligands such as laminin."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " LARGE2 supports the maturation of α‐dystroglycan more effectively than LARGE, and its overexpression enhances laminin receptor activity, whereas its downregulation leads to hypoglycosylation of α‐dystroglycan and consequent loss of extracellular matrix interactions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In addition, LARGE2 has been identified as a direct target of Wnt signaling in colonic epithelial and colorectal cancer cells, linking aberrant Wnt activity to enhanced LARGE2-dependent modification of α‐dystroglycan and increased cell–matrix adhesion that correlates with tumor progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Studies in muscle and kidney further suggest that LARGE2 can compensate for defective LARGE function, highlighting its role in maintaining dystroglycan glycosylation across tissues and its potential as a therapeutic target in dystroglycanopathies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Moreover, recent evidence indicates that LARGE2 may extend its substrate repertoire beyond α‐dystroglycan to include proteoglycans, thereby broadening its impact on cell adhesion and extracellular matrix assembly."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Katsuya Fujimura, Hiromichi Sawaki, Tokiko Sakai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LARGE2 facilitates the maturation of alpha-dystroglycan more effectively than LARGE."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2005.02.082"}], "href": "https://doi.org/10.1016/j.bbrc.2005.02.082"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15752776"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15752776"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Angel Ashikov, Falk F R Buettner, Birgit Tiemann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LARGE2 generates the same xylose- and glucuronic acid-containing glycan structures as LARGE."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Glycobiology (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/glycob/cws153"}], "href": "https://doi.org/10.1093/glycob/cws153"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23135544"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23135544"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Alison K Esser, Michael R Miller, Qin Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.432807"}], "href": "https://doi.org/10.1074/jbc.M112.432807"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23223448"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23223448"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Qin Huang, Michael R Miller, James Schappet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/15384047.2014.987078"}], "href": "https://doi.org/10.4161/15384047.2014.987078"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25455932"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25455932"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Vanessa Dietinger, Cira R García de Durango, Svenja Wiechmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Commun Signal (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12964-020-00561-6"}], "href": "https://doi.org/10.1186/s12964-020-00561-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32586342"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32586342"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Kei-ichiro Inamori, Tobias Willer, Yuji Hara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.597831"}], "href": "https://doi.org/10.1074/jbc.M114.597831"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25138275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25138275"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Prabhjit K Grewal, Jennifer M McLaughlan, Christopher J Moore, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Glycobiology (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/glycob/cwi094"}], "href": "https://doi.org/10.1093/glycob/cwi094"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15958417"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15958417"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Kei-Ichiro Inamori, Aaron M Beedle, Daniel Beltrán-Valero de Bernabé, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LARGE2-dependent glycosylation confers laminin-binding ability on proteoglycans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Glycobiology (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/glycob/cww075"}], "href": "https://doi.org/10.1093/glycob/cww075"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27496765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27496765"}]}]}]}
|
| NCBI Gene ID | 120071 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
LARGE2 has 1,255 functional associations with biological entities spanning 6 categories (disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 39 datasets.
Click the + buttons to view associations for LARGE2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of LARGE2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with LARGE2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of LARGE2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with LARGE2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of LARGE2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing LARGE2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with LARGE2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of LARGE2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by LARGE2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with LARGE2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with LARGE2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding LARGE2 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving LARGE2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving LARGE2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing LARGE2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing LARGE2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by LARGE2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by LARGE2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of LARGE2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of LARGE2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of LARGE2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with LARGE2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by LARGE2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of LARGE2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of LARGE2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| KEGG Pathways 2026 | pathways involving LARGE2 protein from the KEGG Pathways 2026 dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by LARGE2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of LARGE2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of LARGE2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving LARGE2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving LARGE2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving LARGE2 protein from the Reactome Pathways 2024 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of LARGE2 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of LARGE2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of LARGE2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of LARGE2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of LARGE2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with LARGE2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving LARGE2 protein from the WikiPathways Pathways 2024 dataset. | |